バイオロジクスアウトソーシング市場規模：製品、サービス、原料、用途、エンドユーザー別、世界予測、2023年～2032年

バイオロジクスアウトソーシング市場規模は、バイオ製薬企業とアウトソーシング・パートナーの研究開発協力への注目の高まりに牽引され、2023～2032年にCAGR 14.1％で拡大する見通しです。

生物学的製剤の開発・生産は複雑さを増しており、共同パートナーとの提携により、専門知識、技術、リソースの共有が可能になるとともに、高品質な製品の効率的かつタイムリーなデリバリーが促進されています。このような取り組みは、イノベーションを促進し、製品開発期間を短縮し、バイオ医薬品分野の進化する需要に対応するための費用対効果を高めています。

さらに、多くの企業が研究開発努力の最適化に努めていることから、この業界は予測期間中に大きな勢いを得ると思われます。一例を挙げると、2023年10月、バイオ医薬品開発企業のTanvex BioPharma USA Inc.は、バイオ医薬品分野に包括的な生物学的製剤の開発・生産受託サービスを提供するTanvex CDMOを立ち上げました。

製品別では、ワクチン分野の市場規模は2023年から2032年にかけて、高度なワクチン開発・生産サービスの需要増に牽引されて高い需要が見込まれます。世界の予防ヘルスケアへの関心の高まりと感染症罹患率の増加が、効率的でスケーラブルなワクチン製造ソリューションへの需要を高めています。さらに、バイオテクノロジーの急速な進歩や個別化医療の重視の高まりが、同分野の成長をさらに押し上げると思われます。

バイオロジクスアウトソーシング業界は、2032年まで血液関連製品開発アプリケーション・セグメントからの絶大な牽引力を予見しています。血液疾患の蔓延と高度な治療ソリューションに対する需要の高まりが、専門的なバイオロジクスアウトソーシングサービスの必要性を後押ししています。さらに、個別化医療が重視されるようになり、さまざまな血液関連疾患に対する標的生物学的療法の開発も、バイオロジクスアウトソーシング・サービスの採用拡大に寄与しています。

地域別では、アジア太平洋地域のバイオロジクスアウトソーシング産業は、同地域の製薬・バイオテクノロジー分野の拡大に後押しされ、2023年から2032年にかけて力強い成長を記録すると推定されます。高度な生物学的治療に対する需要の急増と個別化医療への注目の高まりが、専門的なアウトソーシングサービスの必要性を高めています。さらに、費用対効果の高い製造能力と熟練した労働力の存在が、効率的で高品質なアウトソーシング・ソリューションを求める世界のバイオ医薬品企業を引き付けており、この地域の産業展望をさらに拡大しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 バイオロジクスアウトソーシング業界考察

• 産業区分
• 業界情勢（2018年～2032年）
• 業界への影響要因
  • 促進要因
    • バイオロジクス製造の複雑化に伴うアウトソーシングサービスの増加
    • CROおよびCMOが提供する費用対効果と効率性
    • CROおよびCMOが提供する技術的優位性
    • 特許切れとバイオロジクスの需要増加
    • CDMOによる先端製造技術への投資の増加
    • 規制コンプライアンスと品質保証の向上
  • 業界の潜在的リスク＆課題
    • 地域によって異なる規制要件
    • 技術力とコストのバランスを取るための絶え間ない技術革新の欠如
    • 社内の専門知識が失われる可能性により、バイオロジクスのアウトソーシングが制限される可能性
• 成長の可能性分析
• COVID-19影響分析
• 規制状況
  • 米国
  • カナダ
  • 欧州
• テクノロジー情勢
• 業界エコシステム
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
  • Merck & Co. Inc
  • AbbVie Inc
  • Thermo Fischer Scientific, Inc.
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 企業シェア分析
• 戦略ダッシュボード

第5章 バイオロジクスアウトソーシング市場：製品別、2018年～2032年

• 主要動向：製品別
• 抗体
  • モノクローナル抗体
  • ポリクローナル抗体
  • 抗体薬物複合体
• ワクチン
• 細胞・遺伝子治療薬
• 組み換えタンパク質
• 血液および血液製剤
• その他の生物製剤

第6章 バイオロジクスアウトソーシング市場：サービス別、2018年～2032年

• 主要動向：サービス別
• 分析試験
• プロセス開発
• 細胞開発
• cGMP製造
• その他サービス

第7章 バイオロジクスアウトソーシング市場：原料別、2018年～2032年

• 主要動向：原料別
• 哺乳類
  • 動物
  • ヒト
• 微生物

第8章 バイオロジクスアウトソーシング市場：用途別、2018年～2032年

• 主要動向：用途別
• 腫瘍学
• 免疫疾患
• 感染症
• ワクチン開発
• 細胞・遺伝子治療
• 血液関連製品開発
• 幹細胞研究
• その他の用途

第9章 バイオロジクスアウトソーシング市場：エンドユーザー別、2018年～2032年

• 主要動向：エンドユーザー別
• 製薬・バイオ医薬品企業
• バイオテクノロジー企業

第10章 バイオロジクスアウトソーシング市場：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • スイス
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第11章 企業プロファイル

• AbbVie Inc.
• Thermo Fischer Scientific Inc.
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Lonza Group AG
• Catalent, Inc
• Wacker Chemie AG（Wacker Biotech GmbH Plc.）
• WuXi AppTec Co., Ltd.
• Samsung Biologics Co., Ltd.
• AGC Biologics
• Scorpius BioManufacturing

Data Tables

• TABLE 1 Market revenue, by product (2022)
• TABLE 2 Market revenue, by service (2022)
• TABLE 3 Market revenue, by source (2022)
• TABLE 4 Market revenue, by application (2022)
• TABLE 5 Market revenue, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Biologics outsourcing market size, by region, 2018 - 2024 (USD Million)
• TABLE 8 Biologics outsourcing market size, by region, 2025 - 2032 (USD Million)
• TABLE 9 Biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 10 Biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 11 Biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 12 Biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 13 Biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 14 Biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 15 Biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 16 Biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 17 Biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 18 Biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Competitive benchmarking of major market players
• TABLE 21 Competitive positioning matrix: Classification criteria
• TABLE 22 Antibodies market size, 2018 - 2024 (USD Million)
• TABLE 23 Antibodies market size, 2025 - 2032 (USD Million)
• TABLE 24 Monoclonal antibodies market size, 2018 - 2024 (USD Million)
• TABLE 25 Monoclonal antibodies market size, 2025 - 2032 (USD Million)
• TABLE 26 Polyclonal antibodies market size, 2018 - 2024 (USD Million)
• TABLE 27 Polyclonal antibodies market size, 2025 - 2032 (USD Million)
• TABLE 28 Antibody drug conjugates market size, 2018 - 2024 (USD Million)
• TABLE 29 Antibody drug conjugates market size, 2025 - 2032 (USD Million)
• TABLE 30 Recombinant proteins market size, 2018 - 2024 (USD Million)
• TABLE 31 Recombinant proteins market size, 2025 - 2032 (USD Million)
• TABLE 32 Vaccines market size, 2018 - 2024 (USD Million)
• TABLE 33 Vaccines market size, 2025 - 2032 (USD Million)
• TABLE 34 Cell and gene therapeutics market size, 2018 - 2024 (USD Million)
• TABLE 35 Cell and gene therapeutics market size, 2025 - 2032 (USD Million)
• TABLE 36 Blood and blood products market size, 2018 - 2024 (USD Million)
• TABLE 37 Blood and blood products market size, 2025 - 2032 (USD Million)
• TABLE 38 Other biologics market size, 2018 - 2024 (USD Million)
• TABLE 39 Other biologics market size, 2025 - 2032 (USD Million)
• TABLE 40 Cell development market size, 2018 - 2024 (USD Million)
• TABLE 41 Cell development market size, 2025 - 2032 (USD Million)
• TABLE 42 Process development market size, 2018 - 2024 (USD Million)
• TABLE 43 Process development market size, 2025 - 2032 (USD Million)
• TABLE 44 Analytical testing market size, 2018 - 2024 (USD Million)
• TABLE 45 Analytical testing market size, 2025 - 2032 (USD Million)
• TABLE 46 cGMP manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 47 cGMP manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 48 Other services market size, 2018 - 2024 (USD Million)
• TABLE 49 Other services market size, 2025 - 2032 (USD Million)
• TABLE 50 Mammalian market size, 2018 - 2024 (USD Million)
• TABLE 51 Mammalian market size, 2025 - 2032 (USD Million)
• TABLE 52 Human market size, 2018 - 2024 (USD Million)
• TABLE 53 Human market size, 2025 - 2032 (USD Million)
• TABLE 54 Animals market size, 2018 - 2024 (USD Million)
• TABLE 55 Animals market size, 2025 - 2032 (USD Million)
• TABLE 56 Microorganisms market size, 2018 - 2024 (USD Million)
• TABLE 57 Microorganisms market size, 2025 - 2032 (USD Million)
• TABLE 58 Infectious diseases market size, 2018 - 2024 (USD Million)
• TABLE 59 Infectious diseases market size, 2025 - 2032 (USD Million)
• TABLE 60 Immunological disorders market size, 2018 - 2024 (USD Million)
• TABLE 61 Immunological disorders market size, 2025 - 2032 (USD Million)
• TABLE 62 Oncology market size, 2018 - 2024 (USD Million)
• TABLE 63 Oncology market size, 2025 - 2032 (USD Million)
• TABLE 64 Cell and gene therapy market size, 2018 - 2024 (USD Million)
• TABLE 65 Cell and gene therapy market size, 2025 - 2032 (USD Million)
• TABLE 66 Vaccine development market size, 2018 - 2024 (USD Million)
• TABLE 67 Vaccine development market size, 2025 - 2032 (USD Million)
• TABLE 68 Blood related product development market size, 2018 - 2024 (USD Million)
• TABLE 69 Blood related product development market size, 2025 - 2032 (USD Million)
• TABLE 70 Stem cell research market size, 2018 - 2024 (USD Million)
• TABLE 71 Stem cell research market size, 2025 - 2032 (USD Million)
• TABLE 72 Other applications market size, 2018 - 2024 (USD Million)
• TABLE 73 Other applications market size, 2025 - 2032 (USD Million)
• TABLE 74 Pharmaceutical and biopharmaceutical companies market size, 2018 - 2024 (USD Million)
• TABLE 75 Pharmaceutical and biopharmaceutical companies market size, 2025 - 2032 (USD Million)
• TABLE 76 Biotechnological companies market size, 2018 - 2024 (USD Million)
• TABLE 77 Biotechnological companies market size, 2025 - 2032 (USD Million)
• TABLE 78 North America biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 79 North America biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 80 North America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 81 North America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 82 North America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 83 North America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 84 North America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 85 North America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 86 North America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 87 North America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 88 North America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 89 North America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 90 North America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 91 North America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 92 North America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 93 North America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 94 U.S. biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 95 U.S. biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 96 U.S. biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 97 U.S. biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 98 U.S. biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 99 U.S. biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 100 U.S. biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 101 U.S. biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 102 U.S. biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 103 U.S. biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 104 U.S. biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 105 U.S. biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 106 U.S. biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 107 U.S. biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 108 Canada biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 109 Canada biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 110 Canada biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 111 Canada biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 112 Canada biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 113 Canada biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 114 Canada biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 115 Canada biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 116 Canada biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 117 Canada biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 118 Canada biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 119 Canada biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 120 Canada biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 121 Canada biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 122 Europe biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 123 Europe biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 124 Europe biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 125 Europe biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 126 Europe biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 127 Europe biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 128 Europe biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 129 Europe biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 130 Europe biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 131 Europe biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 132 Europe biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 133 Europe biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 134 Europe biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 135 Europe biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 136 Europe biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 137 Europe biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 138 Germany biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 139 Germany biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 140 Germany biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 141 Germany biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 142 Germany biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 143 Germany biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 144 Germany biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 145 Germany biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 146 Germany biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 147 Germany biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 148 Germany biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 149 Germany biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 150 Germany biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 151 Germany biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 152 UK biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 153 UK biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 154 UK biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 155 UK biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 156 UK biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 157 UK biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 158 UK biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 159 UK biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 160 UK biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 161 UK biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 162 UK biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 163 UK biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 164 UK biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 165 UK biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 166 France biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 167 France biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 168 France biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 169 France biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 170 France biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 171 France biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 172 France biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 173 France biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 174 France biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 175 France biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 176 France biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 177 France biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 178 France biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 179 France biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 180 Italy biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 181 Italy biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 182 Italy biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 183 Italy biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 184 Italy biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 185 Italy biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 186 Italy biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 187 Italy biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 188 Italy biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 189 Italy biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 190 Italy biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 191 Italy biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 192 Italy biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 193 Italy biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 194 Spain biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 195 Spain biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 196 Spain biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 197 Spain biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 198 Spain biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 199 Spain biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 200 Spain biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 201 Spain biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 202 Spain biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 203 Spain biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 204 Spain biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 205 Spain biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 206 Spain biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 207 Spain biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 208 Switzerland biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 209 Switzerland biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 210 Switzerland biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 211 Switzerland biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 212 Switzerland biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 213 Switzerland biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 214 Switzerland biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 215 Switzerland biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 216 Switzerland biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 217 Switzerland biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 218 Switzerland biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 219 Switzerland biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 220 Switzerland biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 221 Switzerland biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 222 Rest of Europe biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 223 Rest of Europe biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 224 Rest of Europe biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 225 Rest of Europe biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 226 Rest of Europe biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 227 Rest of Europe biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 228 Rest of Europe biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 229 Rest of Europe biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 230 Rest of Europe biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 231 Rest of Europe biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 232 Rest of Europe biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 233 Rest of Europe biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 234 Rest of Europe biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 235 Rest of Europe biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 236 Asia Pacific biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 237 Asia Pacific biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 238 Asia Pacific biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 239 Asia Pacific biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 240 Asia Pacific biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 241 Asia Pacific biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 242 Asia Pacific biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 243 Asia Pacific biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 244 Asia Pacific biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 245 Asia Pacific biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 246 Asia Pacific biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 247 Asia Pacific biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 248 Asia Pacific biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 249 Asia Pacific biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 250 Asia Pacific biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 251 Asia Pacific biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 252 Japan biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 253 Japan biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 254 Japan biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 255 Japan biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 256 Japan biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 257 Japan biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 258 Japan biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 259 Japan biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 260 Japan biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 261 Japan biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 262 Japan biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 263 Japan biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 264 Japan biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 265 Japan biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 266 China biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 267 China biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 268 China biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 269 China biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 270 China biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 271 China biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 272 China biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 273 China biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 274 China biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 275 China biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 276 China biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 277 China biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 278 China biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 279 China biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 280 India biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 281 India biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 282 India biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 283 India biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 284 India biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 285 India biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 286 India biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 287 India biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 288 India biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 289 India biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 290 India biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 291 India biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 292 India biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 293 India biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 294 Australia biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 295 Australia biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 296 Australia biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 297 Australia biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 298 Australia biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 299 Australia biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 300 Australia biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 301 Australia biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 302 Australia biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 303 Australia biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 304 Australia biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 305 Australia biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 306 Australia biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 307 Australia biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 308 Rest of Asia Pacific biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 309 Rest of Asia Pacific biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 310 Rest of Asia Pacific biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 311 Rest of Asia Pacific biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 312 Rest of Asia Pacific biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 313 Rest of Asia Pacific biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 314 Rest of Asia Pacific biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 315 Rest of Asia Pacific biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 316 Rest of Asia Pacific biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 317 Rest of Asia Pacific biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 318 Rest of Asia Pacific biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 319 Rest of Asia Pacific biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 320 Rest of Asia Pacific biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 321 Rest of Asia Pacific biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 322 Latin America biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 323 Latin America biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 324 Latin America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 325 Latin America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 326 Latin America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 327 Latin America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 328 Latin America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 329 Latin America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 330 Latin America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 331 Latin America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 332 Latin America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 333 Latin America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 334 Latin America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 335 Latin America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 336 Latin America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 337 Latin America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 338 Brazil biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 339 Brazil biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 340 Brazil biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 341 Brazil biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 342 Brazil biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 343 Brazil biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 344 Brazil biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 345 Brazil biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 346 Brazil biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 347 Brazil biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 348 Brazil biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 349 Brazil biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 350 Brazil biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 351 Brazil biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 352 Mexico biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 353 Mexico biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 354 Mexico biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 355 Mexico biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 356 Mexico biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 357 Mexico biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 358 Mexico biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 359 Mexico biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 360 Mexico biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 361 Mexico biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 362 Mexico biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 363 Mexico biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 364 Mexico biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 365 Mexico biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 366 Rest of Latin America biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 367 Rest of Latin America biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 368 Rest of Latin America biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 369 Rest of Latin America biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 370 Rest of Latin America biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 371 Rest of Latin America biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 372 Rest of Latin America biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 373 Rest of Latin America biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 374 Rest of Latin America biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 375 Rest of Latin America biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 376 Rest of Latin America biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 377 Rest of Latin America biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 378 Rest of Latin America biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 379 Rest of Latin America biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 380 Middle East & Africa biologics outsourcing market size, by country, 2018 - 2024 (USD Million)
• TABLE 381 Middle East & Africa biologics outsourcing market size, by country, 2025 - 2032 (USD Million)
• TABLE 382 Middle East & Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 383 Middle East & Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 384 Middle East & Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 385 Middle East & Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 386 Middle East & Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 387 Middle East & Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 388 Middle East & Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 389 Middle East & Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 390 Middle East & Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 391 Middle East & Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 392 Middle East & Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 393 Middle East & Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 394 Middle East & Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 395 Middle East & Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 396 South Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 397 South Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 398 South Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 399 South Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 400 South Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 401 South Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 402 South Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 403 South Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 404 South Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 405 South Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 406 South Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 407 South Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 408 South Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 409 South Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 410 Saudi Arabia biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 411 Saudi Arabia biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 412 Saudi Arabia biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 413 Saudi Arabia biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 414 Saudi Arabia biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 415 Saudi Arabia biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 416 Saudi Arabia biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 417 Saudi Arabia biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 418 Saudi Arabia biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 419 Saudi Arabia biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 420 Saudi Arabia biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 421 Saudi Arabia biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 422 Saudi Arabia biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 423 Saudi Arabia biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)
• TABLE 424 Rest of Middle East & Africa biologics outsourcing market size, by product, 2018 - 2024 (USD Million)
• TABLE 425 Rest of Middle East & Africa biologics outsourcing market size, by product, 2025 - 2032 (USD Million)
• TABLE 426 Rest of Middle East & Africa biologics outsourcing market size, by antibodies, 2018 - 2024 (USD Million)
• TABLE 427 Rest of Middle East & Africa biologics outsourcing market size, by antibodies, 2025 - 2032 (USD Million)
• TABLE 428 Rest of Middle East & Africa biologics outsourcing market size, by service, 2018 - 2024 (USD Million)
• TABLE 429 Rest of Middle East & Africa biologics outsourcing market size, by service, 2025 - 2032 (USD Million)
• TABLE 430 Rest of Middle East & Africa biologics outsourcing market size, by source, 2018 - 2024 (USD Million)
• TABLE 431 Rest of Middle East & Africa biologics outsourcing market size, by source, 2025 - 2032 (USD Million)
• TABLE 432 Rest of Middle East & Africa biologics outsourcing market size, by mammalian source, 2018 - 2024 (USD Million)
• TABLE 433 Rest of Middle East & Africa biologics outsourcing market size, by mammalian source, 2025 - 2032 (USD Million)
• TABLE 434 Rest of Middle East & Africa biologics outsourcing market size, by application, 2018 - 2024 (USD Million)
• TABLE 435 Rest of Middle East & Africa biologics outsourcing market size, by application, 2025 - 2032 (USD Million)
• TABLE 436 Rest of Middle East & Africa biologics outsourcing market size, by end-user, 2018 - 2024 (USD Million)
• TABLE 437 Rest of Middle East & Africa biologics outsourcing market size, by end-user, 2025 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Biologics outsourcing industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry segmentation
• FIG 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG 9 Growth potential analysis, by product
• FIG 10 Growth potential analysis, by service
• FIG 11 Growth potential analysis, by source
• FIG 12 Growth potential analysis, by application
• FIG 13 Growth potential analysis, by end-user
• FIG 14 Industry ecosystem
• FIG 15 Porter's analysis
• FIG 16 PESTEL analysis
• FIG 17 Company matrix analysis, 2022
• FIG 18 Competitive analysis of major market players
• FIG 19 Competitive positioning matrix, 2022
• FIG 20 Company market share analysis, 2022
• FIG 21 Strategy dashboard, 2022

Biologics Outsourcing Market size is poised to expand at 14.1% CAGR from 2023-2032 driven by the increasing focus on R&D collaborations between biopharmaceutical companies and outsourcing partners. The rising complexities of biological drug development and production along with collaborative partnerships are enabling the sharing of specialized expertise, technologies, and resources while facilitating the efficient and timely delivery of high-quality products. Such initiatives are fostering innovations, accelerating product development timelines, and enhancing cost-effectiveness for meeting the evolving demands of the biopharmaceutical field.

Moreover, with the large number of companies striving to optimize their R&D efforts, the industry will gain significant momentum in the forecast period. To cite an instance, in October 2023, biopharmaceutical developer Tanvex BioPharma USA Inc. launched Tanvex CDMO to provide comprehensive biologic contract development and production services to the biopharmaceutical sector.

The overall biologics outsourcing industry is segmented based on product, service, source, application, end-user, and region.

With respect to product, the market size from the vaccines segment is anticipated to witness high demand from 2023-2032 driven by the increasing demand for advanced vaccine development and production services. The rising focus on preventive healthcare worldwide and the increasing incidence of infectious diseases is escalating the demand for efficient and scalable vaccine manufacturing solutions. Moreover, the rapid advancements in biotechnology and the growing emphasis on personalized medicine will further boost the segment growth.

Biologics outsourcing industry is anticipated to foresee immense traction from the blood-related product development application segment through 2032. The widespread prevalence of blood disorders and the growing demand for advanced therapeutic solutions are propelling the need for specialized biologics outsourcing services. Moreover, the growing emphasis on personalized medicine and the development of targeted biologic therapies for various blood-related conditions will also contribute to the increasing adoption of outsourced biologics services.

Regionally, the Asia Pacific biologics outsourcing industry is estimated to record robust growth from 2023-2032 fueled by the expanding pharmaceutical and biotechnology sectors in the region. The surging demand for advanced biological therapies and the rising focus on personalized medicine is fueling the need for specialized outsourcing services. Additionally, the presence of cost-effective manufacturing capabilities and skilled workforce is attracting global biopharmaceutical several companies seeking efficient and high-quality outsourcing solutions, further augmenting the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Biologics outsourcing industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Service trends
  • 2.1.5 Source trends
  • 2.1.6 Application trends
  • 2.1.7 End-user trends

Chapter 3 Biologics Outsourcing Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032 (USD Million)
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Growing complexity of biologics manufacturing, leading to increased outsourcing services
    • 3.3.1.2 Cost-effectiveness and efficiency offered by CROs and CMOs
    • 3.3.1.3 Technological advantages offered by CROs and CMOs
    • 3.3.1.4 Patent expiry and increasing demand for biologics
    • 3.3.1.5 Increasing investments in advanced manufacturing technologies by CDMOs
    • 3.3.1.6 Increasing regulatory compliance and quality assurance
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Varying regulatory requirements across regions
    • 3.3.2.2 Lack of constant innovation to balance technological capabilities against costs
    • 3.3.2.3 Potential for loss of in-house expertise may limit biologics outsourcing
• 3.4 Growth potential analysis
  • 3.4.1 By product
  • 3.4.2 By service
  • 3.4.3 By source
  • 3.4.4 By application
  • 3.4.5 By end-user
• 3.5 COVID- 19 impact analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Canada
  • 3.6.3 Europe
• 3.7 Technology landscape
• 3.8 Industry ecosystem
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Merck & Co. Inc
  • 4.1.2 AbbVie Inc
  • 4.1.3 Thermo Fischer Scientific, Inc.
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Company market share analysis, 2022
• 4.6 Strategy dashboard, 2022

Chapter 5 Biologics Outsourcing Market, By Product, 2018 - 2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Antibodies
  • 5.2.1 Monoclonal antibodies
  • 5.2.2 Polyclonal antibodies
  • 5.2.3 Antibody drug conjugates
• 5.3 Vaccines
• 5.4 Cell and gene therapeutics
• 5.5 Recombinant proteins
• 5.6 Blood and blood products
• 5.7 Other biologics

Chapter 6 Biologics Outsourcing Market, By Service, 2018 - 2032 (USD Million)

• 6.1 Key trends, by service
• 6.2 Analytical testing
• 6.3 Process development
• 6.4 Cell development
• 6.5 cGMP manufacturing
• 6.6 Other services

Chapter 7 Biologics Outsourcing Market, By Source, 2018 - 2032 (USD Million)

• 7.1 Key trends, by source
• 7.2 Mammalian
  • 7.2.1 Animals
  • 7.2.2 Human
• 7.3 Microorganisms

Chapter 8 Biologics Outsourcing Market, By Application, 2018 - 2032 (USD Million)

• 8.1 Key trends, by application
• 8.2 Oncology
• 8.3 Immunological disorders
• 8.4 Infectious diseases
• 8.5 Vaccine development
• 8.6 Cell and gene therapy
• 8.7 Blood related product development
• 8.8 Stem cell research
• 8.9 Other applications

Chapter 9 Biologics Outsourcing Market, By End-user, 2018 - 2032 (USD Million)

• 9.1 Key trends, by end-user
• 9.2 Pharmaceutical and biopharmaceutical companies
• 9.3 Biotechnological companies

Chapter 10 Biologics Outsourcing Market, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Switzerland
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 AbbVie Inc.
• 11.2 Thermo Fischer Scientific Inc.
• 11.3 Boehringer Ingelheim International GmbH
• 11.4 Merck & Co., Inc.
• 11.5 Lonza Group AG
• 11.6 Catalent, Inc
• 11.7 Wacker Chemie AG (Wacker Biotech GmbH Plc.)
• 11.8 WuXi AppTec Co., Ltd.
• 11.9 Samsung Biologics Co., Ltd.
• 11.10 AGC Biologics
• 11.11 Scorpius BioManufacturing